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Background: The causes of dural arteriovenous fistula have not been clearly defined. The aim of this study was to
investigate the mechanism of dural arteriovenous fistula formation induced by high intracranial venous pressure
using a rabbit model.
Results: By using rabbit model, dural arteriovenous fistula formation induced by high intracranial venous pressure
could be produced by end-to-end and end-to-side anastomosis of the right side common carotid artery with the
posterior facial vein plus ligation of the contralateral external jugular vein. As compared the post arteriovenous
fistula formation among 1 week, 2 weeks, 3 weeks, and 90 days, the expression level of vascular endothelial growth
factor in the 1- and 2-weeks groups was significantly higher compared with the control group, 3 weeks and 90 days
groups (p ≤0.002). There was significantly higher hypoxia inducible factor-1α expression in the one week group
compared with the control, 2 weeks, 3 weeks, and 90 days groups (p ≤0.002). The results of Western blotting
showed that vascular endothelial growth factor expression level was highest in the 1 week group. The expression
level of vascular endothelial growth factor was significantly different between all groups.
Conclusions: The results of the experiments in our rabbit model indicate that high intracranial venous pressure is a
key for dural arteriovenous fistula formation. Cerebral ischemia caused by lack of cerebral perfusion pressure plays a
key role in the process that leads from high intracranial venous pressure to increased hypoxia inducible factor-1α
expression and then increased vascular endothelial growth factor expression.
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Vascular endothelial growth factorBackground
A dural arteriovenous fistula (DAVF) is an abnormal
connection between dural arteries and dural veins or a
venous sinus or cortical veins. It is a type of intracranial
vascular malformation. Dural arteriovenous fistulas account
for about 10-15% of all intracranial vascular malformations,
6% of supratentorial arteriovenous malformations and
35% of infratentorial arteriovenous malformations [1].
A dural arteriovenous fistula may occur at any site, but
these vascular malformations most commonly occur in
the cavernous sinus, transverse sinus, sigmoid sinus and
superior sagittal sinus (SSS). The main form of treatment* Correspondence: wshsen@126.com
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unless otherwise stated.for DAVF is endovascular embolization [2]. However,
Cha et al. reported the outcomes of 43 DAVF patients
treated with transvenous embolization or transarterial
embolization and concluded that a new approach to
treatment of DAVF is needed [2].
The causes of DAVF have not been clearly defined. It
is thought that there are both congenital and acquired
causes. There is a view that DAVF is an intracranial arterio-
venous malformation and a congenital disease caused by
dural vascular abnormalities [3]. However, few DAVF
cases have involved infants and evidence supporting
this view is lacking. There have been many clinical trials
that have shown that DAVF formation may be caused by
brain trauma, venous sinus inflammation, venous sinus
thrombosis formation, intracranial tumors, brain surgery,
hypercoagulable states, blood molecular abnormalities,td. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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vascular disease. Among the reasons why it is believed
that DAVF is acquired is that the connection between
DAVF and venous sinus thrombosis formation is rela-
tively close. Many investigators have established rat
models of high venous sinus pressure using the com-
mon carotid artery-external jugular vein (CCA-EJV)
anastomosis method and found that 1) the high venous
sinus pressure may induce DAVF; 2) DAVF disappeared
automatically after removing the high venous sinus
pressure; 3) The venous pressure in the high-pressure
groups increased significantly after surgery [4], which
became normal 28 days after surgery; 4) The venous
sinus thrombosis was a risk factor of the high venous
sinus pressure [5]. The key point in favor of DAVF
formation being due to acquired causes is the presence
of high intracranial venous sinus pressure. There are
two theoretical explanations: one is the opening of
“physiological arteriovenous anastomoses,” and the other
is “vascular endothelial growth factor-induced dural
angiogenesis.”
Lawton et al. established a rat model of high venous
sinus pressure using end-to-end anastomosis (EEA)
between the CCA and the EJV [6]. They further trans-
planted the rat dura to the cornea of rabbits and observed
obvious angiogenesis on the cornea. This result suggests
that high venous sinus pressure not only can promote
expression of vascular endothelial growth factor (VEGF),
but also can induce DAVF formation. The researchers
proposed that high intracranial pressure is an important
factor in the pathogenesis of DAVF, and that there are
various causes of vein occlusion and subsequent ob-
struction of the venous circulation, which increases the
intracranial venous pressure and further induces a series
of reactions. They concluded that DAVF formation is a
result of aberrant angiogenesis.
There is strong evidence that factors associated with
angiogenesis are involved in the formation of DAVF.
The aim of this study was to investigate in more detail
the mechanism of DAVF formation induced by high
intracranial venous pressure using a rabbit model. This
study is the first to develop a rabbit model using CCA-
PFV anastomosis to generate a high intracranial venous
pressure model and successfully induce DAVF formation
and may be the first to find that hypoxia inducible
factor-1α (HIF-1α) and vascular VEGF are expressed in




This study was approved by the Institutional Review Board
of Fuzhou General Hospital. One hundread Japanese long-
ear male rabbits (weight: 2.0-2.5 kg) were provided by theShanghai SLAC Laboratory Animal Co.; the license number
is SCXK (Shanghai) 2010-0005. The rabbits were reared in
the Department of Comparative Medicine, Fuzhou General
Hospital in accordance with guide for the care and use of
laboratory animals.
Anesthesia
Anesthesia was induced by injecting 1% sodium pento-
barbital (25 mg/kg) into the ear vein (EV) for procedures
including arteriovenous anastomosis, placement of a cath-
eter in the carotid artery, harvesting the specimens, etc.
One percent sodium pentobarbital was injected through
the catheter into the carotid artery for cerebrovascular
angiography.
Methods
Preparation of animal model
Grouping of experimental animals Fifty male Japanese
long-ear rabbits were randomly divided into five groups,
A-E. In group A (control group) a sham operation was
performed (n = 10). In group B, right-side CCA-posterior
facial vein (PFV) EEA was carried out (n = 10). In group
C, right-side CCA-PFV EEA plus left-side EJV ligation
was performed (n = 10). In group D, right-side CCA-PFV
end-to-side anastomosis (ESA) was carried out (n = 10).
In group E, right-sided CCA-PFV ESA together with
left-sided EJV ligation was performed (n = 10). At 7, 14
and 90 days after surgery, two rabbits were randomly
selected from each group and the number of dural
microvessels was counted after ink perfusion. At 90 days
after surgery, four rabbits from each group were selected
for digital subtraction angiography (DSA) and the status
of DAVF formation was observed.
Another fifty male Japanese long-ear rabbits were randomly
divided into five groups, A-E. In group A (control group) a
sham operation was performed (n = 10). In group B-E (total
n- = 40), righht-side CCA-PFV EEA plus left-side EJV
ligation was performed. In group B, C, D, and E (n = 10/
each group), specimens were taken at one week, two weeks,
three weeks, and 90 days after surgery, respectively, for
further immunohistochemistry (n = 6 for each group) and
western blotting (n = 4 for each group) analyses.
Preparation of model Animals were fasted for 10 h before
surgery without water restriction. One percent sodium
pentobarbital (25 mg/kg) was injected into the left EV.
After anesthesia, the rabbit was fixed on the operating
table. After the neck area was sterilized with Anerdian, a
skin incision was made in the neck. The following proce-
dures were carried out under a microscope.
1. Group A: The bilateral external jugular veins were
dissected subcutaneously. The proximal end was 1 cm
inferior to the junction of the anterior and posterior facial
veins and the EJV. The distal end was 1 cm superior to
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the EJV. The right carotid triangle was exposed and about
2 cm of the CCA was dissected bluntly (Figure 1). Next,Figure 1 Anatomical view of common carotid artery-external jugular
neck incision was made and structures in the left neck were exposed. a. Co
External jugular vein. B. In the preliminary experiment, a significant boundary be
anastomosis between the CCA and EJV. C. Before the anterior facial vein and th
significant fibrous boundary. D. Longitudinal incision of the veins shows that th
jugular vein and one valve in the junction of the posterior facial vein and the e
reflux of venous blood from the chest and abdomen into the head. Without th
of the venous drainage from the head and further induce intracranial ischemia24# intravenous (IV) catheters were punctured into the
posterior facial vein (PFV) and the CCA respectively and
connected to an invasive pressure measuring instrumentvein area. A. The rabbit was placed in the supine position, a midline
mmon carotid artery; b. Anterior facial vein; c. Posterior facial vein; d.
tween the arterial blood and venous blood was observed after end-to-side
e posterior facial vein join to form the external jugular vein, there is a
ere is one valve in the junction of the anterior facial vein and the external
xternal jugular vein. Both valves are pointing cephalically to prevent the
ese valves, the venous blood reflux into the head may cause obstruction
and hypoxia (similar to the situation of hanging upside down).
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incision was closed after topical application of a small
amount of penicillin.
2. Group B: The bilateral external jugular veins and the
right CCA were dissected (the lengths were equal to those
of the sham operation group). The normal artery pressure
and the PFV pressure were measured. The proximal end
of the right EJV was ligated (0.5 cm inferior to the junc-
tion of the anterior and posterior facial veins and the
EJV). The distal end of the anterior facial vein (AFV)
was also ligated (1 cm superior to the junction of the
AFV and the EJV). The PFV was clipped with a vascular
clip (1 cm superior to the junction of the PFV and the
EJV) and cut off about 3 cm superior to the junction of
the PFV and the EJV (across the vein valve). The proximal
end of the CCA was clipped, the distal end was ligated
and cut off, and the lumen of the blood vessel was washed
with 1 mg/ml heparin/saline solution. The stumps of the
CCA and the PFA were stained with methylene blue and
then washed with 1 mg/ml heparin/saline solution. End-
to-end anastomosis between the CCA and the PFV was
carried out using 9-0 suture line. The anastomotic patency
was verified after anastomosis. The PFV pressure was
measured after anastomosis, and the incision was closed
after topical application of a small amount of penicillin.
3. Group C: The right CCA, EJV and the left EJV were
dissected. The left EJV was ligated using 4-0 suture line.
Other procedures were the same as in group B.
4. Group D: The bilateral external jugular veins and
right CCA were dissected (the length of dissection was
the same as in the sham operation group). The normal
artery pressure and the PFV pressure were measured.
The proximal end of the right EJV and the distal end of
the AFV were ligated. The PFV was clipped with a clip
and cut off at a point 3 mm distal to the junction of the
PFV and the EJV. The lumen of blood vessel was washed
with 1 mg/ml heparin/saline solution. Two vascular clips
were used to clip the CCA, and the distance between
two clips was about 1.5 cm. An incision was made along
the vessel wall using a microsissor, and the length was
1.5 times the length of the vascular diameter. The lumen
of the blood vessel was washed with 1 mg/ml heparin/
saline solution immediately. The incision in the CCA
and the stump of the PFV were stained with methylene
blue and washed with 1 mg/ml heparin/saline solution.
End-to-side anastomosis between the common carotid
artery and the PFV was carried out using 9-0 suture line.
The anastomotic patency was verified after anastomosis.
The PFV pressure was measured after anastomosis, and
the incision was closed after topical application of a
small amount of penicillin.
5. Group E: The right CCA, EJV and the left EJV were
dissected. The left EJV was ligated using 4-0 suture line.
Other procedures were the same as in group D.Additional file 1: Figure S1 represented schematic draw-
ings of groups A-E, which illustrates the vessels that were
occluded and anastomosed as well as the collaterals.
Measurement of pressures
Dissection of the CCA and measurement of the CCA
pressure were carried out in all 50 rabbits in the five
groups (A-E).
Measurement of blood pressure in the common carotid
artery The right CCA was dissected about 2 cm and a 24#
IV catheter was inserted caudally, fixed with a vascular clip
and connected with an invasive pressure measuring instru-
ment (Figure 2A). The pressure was adjusted to zero at the
heart level. After the reading became stable, photographing
and recording were carried out (Figure 2B).
Measurement of posterior facial vein pressure Dissec-
tion of the PFV and measurement of the PFV pressure
were carried out for all 50 rabbits in the five groups (A-E).
The total length of dissection of the right EJV, and anter-
ior and posterior facial veins was about 2 cm. A 24# IV
catheter was inserted cephalically through the vein valve
into the PFV and connected with an invasive pressure
measuring instrument after fixation (Figure 2C). The pres-
sure was adjusted to zero at the heart level. After the
reading became stable, photographing and recording
were carried out (Figure 2D).
Measurement of posterior facial vein pressure after
anastomosis For the 40 rabbits in groups B-E, the anas-
tomotic patency was verified after CCA-PFV anastomosis
and before sacrifice and the PFV pressure was measured.
At the PFV side of anastomosis, a 24# IV catheter was
inserted cephalically and connected with an invasive
pressure measuring instrument after fixation (Figure 2E
and 2G). The pressure was adjusted to zero at the heart
level. After the reading became stable, photographing
and recording were carried out (Figure 2F and 2H).
Ink perfusion
Two rabbits were selected from group A and at 7, 14,
and 90 days after CCA-PFV anastomosis in groups B-E
for ink perfusion in the head and neck. Microvessel
density of the harvested dura was counted.
DSA examination
At 90 days after surgical intervention, four rabbits were
selected from the five groups for DSA examination of
the head and neck. Detailed procedures were as follows:
Catheter placement in the carotid artery After being
anesthetized by EV injection of 1% pentobarbital sodium
(1% 25 mg/kg), the rabbit was placed in the supine
Figure 2 Measurement of the pressure of the right cervical blood vessels (left is the cephalic side). A. Fixation method and measurement
of the common carotid artery pressure: An IV catheter was inserted caudally into the common carotid artery and fixed with a vascular clip. B. The
normal artery pressure. C. Measurement of the posterior facial vein pressure: An IV catheter was inserted cephalically into the posterior facial vein and
no special fixation was carried out. D. The normal posterior facial vein pressure. E. Measurement of the posterior facial vein pressure after end-to-end
anastomosis (EEA): An IV catheter was inserted cephalically into the posterior facial vein and fixed. F. The posterior facial vein pressure after EEA showed an
arterial pressure-like change. G. Measurement of the posterior facial vein pressure after end-to-side anastomosis: An IV catheter was inserted cephalically
into the posterior facial vein and fixed. H. The posterior facial vein pressure after end-to-side anastomosis shows an arterial pressure-like change.
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was carried out along the original neck incision. The
site of the right arteriovenous anastomosis was carefully
dissected. There were numerous new veins formed
around the site. After verifying the anastomotic patency,
the posterior facial vein pressure was measured. The site
of anastomosis was ligated and fixed. The left CCA was
dissected and a 24G IV catheter was placed in it. Thecatheter was filled with 1 mg/ml heparin and fixed
securely. The neck incision was closed.
Obtaining of DSA images After being anesthetized by
CCA injection of 1% pentobarbital sodium, the rabbit
was placed in the supine position and fixed on the DSA
table. After adjusting the machine position, iohexol-300
was injected through the catheter placed in the CCA for
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were then taken.
Immunohistochemistry
Specimens of occipital cortex and dura were collected
from the control, one week, two weeks, three weeks,
and 90 days groups, respectively (n = 6 each group) for
HIF-1α and VEGF immunohistochemistry. The occipital
cortex was chosen because it is the area first affected by
the impact of anastomosis generating high intracranial
venous pressure and it is conveniently located for conduct-
ing experiments. Immunohistochemistry was performed
in 5-mm sections of tissues that were formalin-fixed and
paraffin-embedded. Reference sections were stained with
hematoxylin and eosin (HE). The tissue sections were
incubated with the following primary antibodies: VEGF
(C-1) (1:100; Santa Cruz, Santa Cruz, CA, USA), HIF-1α
(1:200; H-206; Santa Cruz, Santa Cruz, CA, USA) at 4°C
for overnight. Then incubated with a horseradish peroxid-
ase-conjugated mouse anti-rabbit secondary antibody
(1:1000). Immunohistochemical analysis was performed
using the s 3,3’-Diaminobenzidine (DAB) (Sigma-Aldrich,
St Louis, MO, USA) method. All specimens were analyzed
under inverted microscope and photographic systems
Olympus BX51 (Olympus, Tokyo, Japan). The visual fields
with 100× and 200× magnification were 1.8-2 mm2 and
0.9-1 mm2, respectively. The percentage was expressed
as stained “positive” cell divided by the total number of
cells under the same magnifications (i.e., 100× or 200×)
of the same visual areas. The criteria used to assign the
numerical values to expression levels were the follow-
ing: - = 0%, + = >0%-25%, ++ = 26%-50%, +++ = 51%-
75%, ++++ = >75%.
Western blotting
Specimens of occipital cortex and dura were collected
from the control, one week, two weeks, three weeks,
and 90 days groups, respectively (n = 4 each group) for
Western blotting. Specimens were lysed in RIPA buffer
(Millipore, Billerica, MA, USA), and the concentration
of the protein extracts was determined by the Bradford
assay (Bio-Rad Protein Assay Kit 500-0201; Life Science,
Hercules, CA, USA). A total of 40 μg total protein was
separated by 10% SDS-PAGE and then transferred onto
a polyvinylidene fluoride (PVDF) membrane, which was
incubated in blocking buffer of 5% non-fat milk in TBS
containing 0.1% Tween-20. The membrane was then
probed with a primary antibodies specific for VEGF (C-1)
(1:200; Santa Cruz, Santa Cruz, CA, USA ), HIF-1α (1:200;
H-206; Santa Cruz, Santa Cruz, CA, USA), and the
loading control, α-tubulin (52 kDa, 1:3000; 2125; Cell
Signaling Technology) at 4°C for overnight. The mem-
branes were next incubated with a horseradish peroxidase-
conjugated mouse anti-rabbit secondary antibody (1:1000).Immunoreactive bands were visualized using enhanced
chemiluminescent HRP Substrate (Millipore). Results
represent three independent experiments. Densitometric
analysis was performed by GE image scanner Quantity
One software (Fairfield, CT, USA).
Statistical analysis
Continuous data were expressed as the mean with standard
deviation. Categorical data were expressed by the number
in each group. The comparisons of the animals’ weight,
arterial blood pressure, and venous blood pressure among
the five groups of rabbits that underwent various operations
as well as the comparisons of the levels of expressions of
VEGF and HIF-1α by Western blotting among the five
groups at baseline, 1 week, 2 weeks, 3 weeks, and 90 days
were analyzed, respectively, by one-way ANOVA (analysis
of variance) together with Bonferroni post-hoc tests.
Changes of venous blood pressure from baseline to post-
operation were compared and analyzed by the paired
t-test. The associations of anastomosis patency versus
operation groups were analyzed by the Fisher’s exact
test. The comparisons of the ordinal data (VEGF and
HIF-1α expression levels by immunohistochemistry) among
all five groups and post-hoc test for each two groups
were performed by the non-parametric Kruskal-Wallis
test and Mann-Whitney test with Bonferroni correction.
All statistical assessments were two-tailed and evaluated
at the 0.05 level of significant difference. Statistical analyses
were performed using SPSS 15.0 statistics software (SPSS
Inc, Chicago, IL, USA).
Results
The comparisons of baseline weight and blood pressure
among the five groups (A-E) are summarized in Table 1.
There were no significant differences among the five
groups.
All animals in the groups B and C survived after surgery.
Due to excessively high intracranial venous pressure, two
rabbits in groups D and E died within 3 days after surgery.
The rate of anastomotic patency was 80% in the group B,
90% in group C, 60% in group D and 50% in group E.
Peri-operative blood pressure
No significant differences in the frequency of anastomosis
patency were observed postoperatively among groups
B-E. Post-operative venous blood pressure in the sham
operation group (group A) did not change significantly
compared to baseline. All four high venous pressure
groups (groups B-E) had significantly increased venous
blood pressure immediately after surgery and before
sacrifice compared with baseline (p ≤ 0.001), and had
significantly increased venous blood pressure immedi-
ately after surgery and before sacrifice compared to the
control group (p < 0.001). The venous blood pressure of
Table 1 Summary of the peri-operative characteristics of the animals in the five groups
A (n = 10) B (n = 10) C (n = 10) D (n = 10) E (n = 10) P-value
Baseline
Weight (kg) 2.23 (0.19) 2.29 (0.19) 2.23 (0.20) 2.30 (0.16) 2.17 (0.16) 0.508
Systolic artery BP (mmHg) 109.60 (4.84) 112.40 (12.52) 108.30 (8.42) 108.20 (11.58) 105.70 (12.39) 0.698
Diastolic artery BP (mmHg) 98.80 (7.58) 101.90 (10.58) 96.60 (12.95) 99.40 (10.20) 92.88 (7.57) 0.417
Venous BP (mmHg) 5.90 (1.45) 5.90 (2.02) 7.00 (2.21) 6.40 (1.26) 5.80 (2.15) 0.572
Immediately after operation
Frequency of anastomosis patency 10/10 8/10 9/10 6/10 5/10 0.052
Systolic venous BP (mmHg) 6.20 (1.69) 49.50 (14.77)*a 54.70 (15.23)*a 47.90 (16.14)*a 46.50 (19.88)*a <0.001
Diastolic venous BP (mmHg) 42.60 (13.08)*a 45.00 (12.07)*a 42.50 (15.06)*a 41.10 (18.72)*a <0.001
Before sacrifice
Venous BP (mmHg) 6.20 (1.87) 41.60 (12.71)*a 42.90 (10.73)*a 25.80 (13.45)*†a 26.00 (13.16)*†a <0.001
Anastomosis patency is presented as number of each group; other data are presented as mean and standard deviation. A: sham group, B: end-to-end anastomosis
group, C: end-to-end anastomosis + ligation of the contralateral EJV group, D: end-to-side anastomosis group, E: end-to-side anastomosis + ligation of the contralateral
EJV group. BP: Blood pressure. *indicates a significant change compared to group A, †indicates a significant change compared to group B and group C. aindicates a
significant change compared to baseline level of venous BP.
In each group of ten rabbits six animals were used for ink perfusion and four were used for DSA examination/.
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compared with the animals in the D and E groups (41.6
and 42.9 mmHg vs. 25.8 and 26.0; p ≤ 0.003), respectively.
However, there were no significant differences between
groups B and C or between groups D and E groups
(Table 1).
Cerebral ink perfusion
Convex microvascular surface of dural capillaries com-
prised parasagittal sinuses 2 mm wide and 3 mm above
the transverse sinuses were included for observations and
comparisons. The dural capillaries were counted as num-
bers of microvessels/per mm2. The dural microvessel count
of control group A was 12 ± 2/mm2 and increased slightly
to 15 ± 2/mm2 at 14 days post-operation. After 90 days,
the dural microvessel count were significantly increased
among groups B, C, D, and E as 36 ± 4 mm2, 39 ± 5 mm2,
33 ± 3 mm2, and 35 ± 4 mm2, respectively. The results of
cerebral ink perfusion are illustrated in Figure 3.
DSA findings
DSA examinations were carried out for four rabbits from
each group (A-E) 90 days after surgery. DSA images in
the arterial phase are shown in Figure 4 and in the
venous phase in Figure 5. In each figure an image from
an animal in the control group is shown next to an
image from an animal in group C. In group A, the blood
vessels were unobstructed, no abnormal veins were
observed, and the time for blood circulation was about
11-15 s. In groups B, C, D and E, the blood vessels were
tortuous and DAVF and AVF in the ear and eye regions
were observed. In some animals, two or more than two
AVFs were observed. Twenty-two cases of AVF were
observed in 16 rabbits. Among them, 7 cases were DAVFs,and therefore rate of DAVF formation was 43.75% (7/16).
The DAVFs were mainly located in the SSS, cavernous
sinus, transverse sinus. AVFs occurred at two sites in 6
animals and at three sites in one animal. DAVFs were
drained via the SSS, transverse sinus and posterior facial
vein; AVFs in the eye were drained via the anterior
facial vein; AVFs in the ear were drained via the posterior
facial vein; and the cervical AVF was also drained via the
posterior facial vein. In the groups B, C, D and E, the
circulation time was extended about 32-40 s (mean, 35 s).
The circulation time was extended significantly in the
venous phase while it was not obviously extended in the
arterial phase (about 5 s). Circulation time was extended
significantly in the high-pressure groups (equal to or
more than 35 s) compared to group A; especially in the
venous phase it was more obvious. It is suggested that
the increased intracranial venous system pressure resulted
in the obstruction of the blood drainage.
VEGF and HIF-1α expression levels by
immunohistochemistry
VEGF expression in the occipital cortex and vessels in
the pia mater originating from the occipital lobe in the
1 week and 2 weeks groups were significantly higher than
in control group, 3 weeks, and 90-days groups (p ≤ 0.002).
Compared with the animals in control group, the SSS of
the animals in the 2 weeks groups showed significantly
higher VEGF expression level (p = 0.002). Compared with
the control group and the 2 weeks, 3 weeks, and 90-days
groups, the one week group had shown higher HIF-1α
expression in the occipital cortex, vessels in the pia mater
and SSS (p ≤ 0.002; Table 2). VEGF and HIF-1α expression
levels by immunohistochemistry were depicted in Figures 6
and 7, respectively.
Figure 3 Cerebral ink perfusion. A. The dural blood vessels were parallel in the control group, there were few connections between the parallel blood
vessels (100×). B. The dural blood vessels were parallel in the high-pressure groups 14 days after surgery, there were some connections between blood
vessels and some enlarged veins (100×). C. The dural blood vessels were still parallel in the high-pressure groups 90 days after surgery, the blood-vessel
enlargement was significant and the amount of connections between blood vessels increased significantly, and the diameters of the blood vessels for
connection were relatively thin (100×). D. The artery was directly connected with the enlarged vein (200×).
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The patterns of VEGF expression level in the dura of the
occipital lobe as well as HIF-1α expression level in the
cortex of the occipital lobe and SSS were similar. The
peak expression levels were observed in the 1 weekFigure 4 DSA arterial phase. A. Group A after 90 days, the left common
phase toward the common carotid artery (CCA), internal carotid artery (ICA), e
the left common carotid artery angiography lateral arterial phase shows CCA,
the vertebral artery (VA), basilar artery (BA), DAVF, eye AVF, and the superior sagroup, followed by the 2 weeks, 3 weeks, 90 days and
control groups. The mean expression levels for each
corresponding control, 1 week, 2 weeks, 3 weeks, and
90 days were 10.1, 27.2, 34.1, 16.9, and 11.8 for VEGF
expression in the dura of the occipital lobe, respectively;carotid artery angiography showed normal radiographs in the arterial
xternal carotid artery (ECA ), and ear artery (EA); B. group C after 90 days,
ECA, ICA, and EA toward tortuous, and visible abnormal development of
gittal sinus (SSS).
Figure 5 DSA venous phase. A. Group A after 90 days, the results from left common carotid artery angiography lateral veins at late stage had
shown the surface normal to the posterior facial vein (PFV), before intravenous anterior facial vein (AFV), external jugular vein (EJV), and ear vein
(EV) all run regularly; B. group C after 90 days, the left common carotid artery angiography lateral veins at late stage had shown ophthalmic vein
(OV), intracranial venous and EV all had stranded flow.
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cortex of the occipital lobe, respectively, and 9.4, 35.6,
26.7, 17.7, 10.6 for HIF-1α expression level in the SSS,
respectively. All comparisons between each two groups
were statistically significant (Figure 8).
Discussion
In this study, using a rabbit model, we showed that
DAVF formation could be produced by EEA and ESA of
the right side CCA-PFV + ligation of the contralateral
EJV. Our results indicated that the mechanism involved
anatomosis generating high intracranial venous pressure
which caused ischemia and hypoxia which increased
the expression of HIF-1α and subsequently VEGF in
the occipital cortex, pial vessels from the same occipital
cortex, and the dura on SSS after surgery. This is the
first report of a rabbit model using CCA-PFV anasto-
mosis to generate high intracranial venous pressure and
successfully induce DAVP formation. It also may be the
first report of a study using this rabbit model in which
HIF-1α and VEGF were expressed in sequential order. The
clinical implications of our findings are that understanding
the details of the mechanisms of DAVF formation may
permit the development of better therapeutic strategies
for treating this condition.
Mechanism of DAVF formation
Intracranial high venous pressure appears to the key to
DAVF formation. High venous pressure may result from
venous sinus thrombosis or congenital thrombosis. There
are various opinions about how high venous sinus pressure
induces DAVF and many studies have been carried out
that have focused on this issue. Sandalcioglu et al. found
that the plasma VEGF level was significantly higher inpatients with cerebral vascular malformations compared
with healthy people [7]. According to this result, they
presumed that VEGF may play a special role in cerebral
vascular malformations. Kim et al. analyzed the plasma
VEGF level in 13 patients with cerebral malformations
before and after treatment and found that the plasma
VEGF level was significantly lower before surgery in
these patients compared with healthy people, and further
decreased within 24 h after surgery but became normal by
30 days after surgery [5]. Therefore, they suggested that
abnormal vascular proliferation may play an important
role in cerebral arteriovenous malformations. Although
in both studies it was concluded that VEGF may play
an important role in cerebral arteriovenous malforma-
tions, the changes of the plasma VEGF level were directly
opposite in these two studies. Therefore, the relationship
between VEGF and cerebral arteriovenous malformation
needs further clarification.
Role of vascular growth factors
Many investigators have studied the pathology of dura
removed from DAVF patients and found that there were
changes of various vascular growth factors. Tirakotai
et al. found that the rates of VEGF and HIF-1α expres-
sion in the dura of DAVF patients were 100% and the
rates of transforming growth factor α (TGFα) and basic
fibroblast growth factor (bFGF) were 75% [8]. Increased
VEGF, TGFα and bFGF expression mainly occurred in
the endothelial cell layer. Uranishi et al. compared the
dural VEGF and bFGF expression in patients with DAVF
and associated venous sinus thrombosis and in patients
who died of non-central nervous system diseases and
found that the VEGF and bFGF expression levels were
relatively low in the control group; the main locations of












VEGF expression level in occipital cortex* - 1 0 0 1 1 <0.001
± 5 0 0 5 5
+ 0 6 1 0 0
++ 0 0 5 0 0
VEGF expression level in vessels in pia mater* - 2 0 0 1 2 <0.001
± 4 0 0 5 4
+ 0 6 2 0 0
++ 0 0 4 0 0
VEGF expression level in superior sagittal sinus† - 1 0 0 0 1 0.004
± 5 4 0 2 0
+ 0 2 6 4 5
++ 0 0 0 0 0
VEGF expression level in vessels in dura mater - 1 0 0 0 1 0.002
± 5 5 1 1 0
+ 0 1 5 5 5
++ 0 0 0 0 0
HIF-1α expression level in cortex of occipital lobe‡ - 2 0 0 1 0 <0.001
± 4 0 1 5 6
+ 0 0 5 0 0
++ 0 2 0 0 0
+++ 0 4 0 0 0
HIF-1α expression level in vessels in pia mater‡ - 0 0 0 2 1 <0.001
± 6 0 1 4 5
+ 0 0 5 0 0
++ 0 1 0 0 0
+++ 0 5 0 0 0
HIF-1α expression level in superior sagittal sinus‡ - 2 0 0 0 1 <0.001
± 4 0 1 1 5
+ 0 0 5 5 0
++ 0 2 0 0 0
+++ 0 4 0 0 0
HIF-1α expression level in dura mater‡ - 2 0 0 0 1 <0.001
± 4 0 1 2 5
+ 0 0 5 4 0
++ 0 2 0 0 0
+++ 0 4 0 0 0
*Higher expression levels were observed in the 1 week and 2 weeks groups compared to control group, 3 weeks, and 90 days groups. The percentage was
expressed as stained “positive” cell divided by the total number of cells under the same magnifications (i.e., 100× or 200×) of the same visual areas. The criteria
used to assign the numerical values to expression levels were the following: - = 0%, + = >0%-25%, ++ = 26%-50%, +++ = 51%-75%, ++++ = >75%. †Higher
expression level was observed in the 2 weeks group compared to control group. ‡Higher expression levels were observed in the one week group compared to
control group, 2 weeks, 3 weeks, and 90 days groups.
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layer, middle vascular layer and perivascular tissue [9].
In the DAVF group, the locations were the same withregard to expression level, but bFGF expression was
stronger and the concentration of staining was higher.
In addition, the bFGF expression could be observed in
Figure 6 Immunohistochemical VEGF staining. Each of the five groups included six animals: A. One week group, occipital cortex and leptomeningeal
vessels were VEGF (+), the dura mater was VEGF (±) (VEGF staining , 10 × 10); B. Two weeks group, occipital cortex soft meningeal blood vessels showed
VEGF (+ +), the dura mater was VEGF (+) (VEGF staining, 10 × 10); C. three weeks group, occipital cortex and leptomeningeal vessels were VEGF (±), the
dura mater was VEGF (+) (VEGF staining , 10 × 20); D. control group, occipital cortex and leptomeningeal vessels were VEGF (±) (VEGF staining , 10 × 10);
E. 90 days group, dura was VEGF (+), and visible blood vessels increased in number (VEGF staining , 10 × 10); F. 90 day group, dura was VEGF
(+), positive-stained granules are mainly located in vascular endothelium and vascular extracellular matrix and the number of visible blood
vessels increased, lumen expansion (VEGF staining , 10 × 20).
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http://www.biomedcentral.com/1471-2202/15/101the arterioles on the wall of the dural sinus. VEGF
expression was observed in the wall of the diseased
dural sinus and the arterioles with organized thrombus
in the venous sinus. Tirakota et al. found that the dural
proliferating cell nuclear antigen (PCNA), VEGF, ephrin-
B2 and Fik-1 and Fit-1 (VEGF receptors) expression
levels were 50%, 100%, 86.7% , 33.3% and 66.7% higher,
respectively, in DAVF patients [10]. VEGF and ephrin-B2
expression were mainly located in the endothelial cell
layer. Investigators have noted that it is obvious that
DAVF patients have obvious changes of the vasculargrowth factors in the endothelial cells [9,11] and the
peripheral tissues [9]. Li et al. used rats to investigate
whether the VEGF signaling pathway has an important
role in DAVF development found that VEGF and its
receptor may play have such a role in DAVF induced by
venous hypertension [12].
The vascular remodeling (expression of endothelial
growth factor and angiogenesis) due to vascular lesion-
induced high venous pressure and hypoxia [8,10] or
hemodynamic changes [9] has been proposed to be the
key factor for new DAVF formation. Zhu et al. exposed
Figure 7 HIF-1α immunohistochemical staining. Each of the five groups included four animals: A. One week group, occipital cortex and
leptomeningeal vessels were HIF-1α (+ + +) (HIF-1α staining , 10 × 10); B. Two weeks group, occipital cortex and soft meningeal blood vessels
showed HIF-1α (+) (HIF-1α staining , 10 × 10); C. three weeks group, pial vessels in occipital cortex had HIF-1α (±) (HIF-1α staining , 10 × 10);
D. control group, occipital cortex and leptomeningeal vessels were HIF-1α (±) (HIF-1α staining , 10 × 10); E. 90 day group, dura was HIF-1α (±),
the number of visible blood vessels increased (HIF-1α staining , 10 × 10).
Wang et al. BMC Neuroscience 2014, 15:101 Page 12 of 15
http://www.biomedcentral.com/1471-2202/15/101rats to venous hypertension for various periods of time
and found that compared with controls there was a sig-
nificant increase in the expression of hypoxia inducible
factor-1α (HIF-1α) [10]. There was also a significant in-
crease in the expression of vascular endothelial growth
factor (VEGF). The authors concluded that angiogenesis
was stimulated by venous hypertension through a mech-
anism that did not involve ischemia. Shin et al. used
three DAVF rat models and found that the model that
employed CCA-EJV anastomosis and bipolar coagulation
of the vein that drains the transverse sinus and sagittal
sinus thrombosis to induce venous hypertension had thehighest level of VEGF, and in this model VEGF peaked
one week following surgery thus appearing to demonstrate
that an angiogenic growth factor contributed to DAVF
formation [13].
High venous sinus pressure
Many researchers have established rat models of high ven-
ous sinus pressure using CCA-PFV anastomosis method
and found that (1) the high venous sinus pressure may
promote the expression of vascular growth factors [14];
(2) the high venous sinus pressure may induce DAVF [8];
(3) strong VEGF expression could be observed in the
Figure 8 VEGF and HIF-1α expression levels by Western blot
analysis. Each of the five groups included four animals. Specimens
were collected from the control, one week, two weeks, three weeks,
and 90 days groups, respectively. A. VEGF expression level in dural of
occipital lobe; B. HIF-1α expression level in cortex of occipital lobe;
C. HIF-1α expression level in superior sagittal sinus. *Statistically
significant compared to control group. †Statistically significant
compared to 1 week group. ‡ Statistically significant compared to 2
weeks group. § Statistically significant compared to 3 weeks group.
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http://www.biomedcentral.com/1471-2202/15/101astrocytes [7], venous endothelial cells, connective tissues
around the venous sinus, dural endothelial layer of the
dura, cerebral cortex and basal ganglia [15], etc.; and (4)
there was a certain correlation between the extent of
VEGF expression and the level of pressure as VEGF ex-
pression increased along with the increase of the pressure.
We believe that high intracranial pressure is the key
factor in DAVF formation. There are “direct physiological
arteriovenous pathways” in the dural vascular structures.
These physiological pathways are open when there is a
high venous pressure, which results in fistula formation.
However, the blood flow in these fistulae is limited
and cannot form a DAVF immediately; further vascular
remodeling is required. During the observation following
dural ink perfusion in rabbits 1-3 weeks after surgery,
enlargement of these direct pathways could be observed
without fistula formation. The high venous sinus pressure
may result in decreased cerebral perfusion pressure and
induce cerebral ischemia. Hypoxia after high intracranial
venous pressure leads to the following pathophysiological
changes: 1) HIF expression is increased and then VEGF is
activated, 2) VEGF has the highest expression in the sinus
surrounding the most severe ischemia, 3) a dural venous
sinus is formed and dural neovascularization is observed
to increase, 4) part of the neovascularization is connected
with the original artery which results in arterial blood
flowing directly into the sinus resulting in DAVF forma-
tion. To adapt to the cerebral ischemia and improve the
hypoxic environment, vascular growth factors including
HIF-1α, VEGF, etc. are highly expressed. The long-distance
arteriovenous direct pathways can significantly increase the
vascular resistance and reduce the venous pressure. If the
distance is short, the capillary pressure and venous pressure
obviously increase and remodeling of this kind of direct
pathway may occur under the effect of vascular growth
factors and smooth muscle cells appear in the peripheral
area to form a DAVF [16]. During the observation of rat
dural specimens [17], these kind of specific pathways were
most commonly seen in the dura of adjacent sinuses.
Therefore, DAVF formation easily occurs nearby the
sinus. We consider that the high venous sinus pressure is
a “trigger point” inducing DAVF formation. The detailed
processes are illustrated in Figure 9.
Figure 9 Flow diagram illustrating a proposed mechanism for explaining how high venous sinus pressure can result in DAVF formation.
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Ours study had limitations because of our rabbit model
had the following shortcomings: (1) We considered that
the PFV pressure could indirectly reflect the intracranial
venous pressure. Because of the effect of anatomical
structures there is a certain deviation in this value. (2)
Because the diameter of the PFV is more than two times
that of the CCA it is difficult to form the arteriovenous
anastomosis. (3) We did not design an animal group
with venous sinus thrombosis and the effect of throm-
bosis on DAVF formation was not studied, (4) DSA
examination was carried out after placing a catheter in
the left CCA. The examination of the intracranial blood
vessels was insufficient and changes in the right sideveins were not evaluated. There is no proper justification
on the number of animals used for this study Even we
had budget limitations, we attempted to maximize the
whole experimental design to obtain as much data as
possible within 100 rabbits usedin this study.
Conclusions
The results of our rabbit model experiments indicate
that high intracranial pressure plays a key role in DAVF
formation. Cerebral ischemia caused by a lack of cere-
bral perfusion pressure plays a key role in a process that
leads from high intracranial venous pressure to increased
HIF-1α expression and subsequently increased VEGF
expression.
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Additional file 1: Figure S1. S1A. Schematic drawings of group A
(the control group). Group A. a: superior sagittal sinus (SSS); b: right-side
posterior-facial vein (PFV); c: right-side anterior-facial vein (AFV); d:
right-side common carotid artery (CCA); e: right-side vertebral artery (VA).
S1B. Schematic drawings to illustrate the vessel that were occluded and
anastomosed in group B and group C. Group B (right-side CCA-PFV EEA)
and group C (right-side CCA-PFV EEA plus left-side EJV ligation). a: superior
sagittal sinus (SSS); b: right-side posterior-facial vein (PFV); c: right-side
anterior-facial vein (AFV); d: right-side common carotid artery (CCA); e:
right-side vertebral artery (VA); f: residue of ligation of right common carotid
artery; g: right-side CCA-PFV EEA; h: right-side EJV ligation; j: left-side EJV
ligation. Arrow indicated blood stream direction. S1C. Schematic drawings
to illustrate the vessel that were occluded and anastomosed in group D
and group E. Group D: right-side CCA-PFV end-to-side anastomosis and
group E right-side CCA-PFV end-to-side anastomosis plus left-side EJV
ligation. a: superior sagittal sinus (SSS); b: right-side posterior-facial vein
(PFV); c: right-side anterior-facial vein (AFV); d: right-side common carotid
artery (CCA); e: right-side vertebral artery (VA); g: right-side CCA-PFV
end-to-side anastomosis; h: right-side EJV ligation; j: left-side EJV
ligation. Arrow indicated blood stream direction.
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